AGL agilon health, inc.

NYSE agilonhealth.com


$ 0.70 $ -0.09 (-10.63 %)    

Tuesday, 04-Nov-2025 18:51:27 EST
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 0.7242
$ 0.81
$ 0.69 x 1
$ 0.78 x 10
-- - --
$ 0.71 - $ 6.08
12,102,344
na
300.24M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-26-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 agilon-health-lowers-fy2025-sales-guidance-from-5850b-6025b-to-5810b-5830b-vs-5815b-est

Fiscal Year 2025 GuidanceGuidance reflects the full year impact of approximately $150 million from lower-than-expected risk adj...

 agilon-health-q3-eps-027-misses-016-estimate-sales-1435b-beat-1423b-estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.16) ...

 wells-fargo-maintains-overweight-on-agilon-health-lowers-price-target-to-15

Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $5 ...

 bernstein-downgrades-agilon-health-to-market-perform-lowers-price-target-to-14

Bernstein analyst Lance Wilkes downgrades Agilon Health (NYSE:AGL) from Outperform to Market Perform and lowers the price ta...

 jefferies-maintains-hold-on-agilon-health-lowers-price-target-to-11

Jefferies analyst Jack Slevin maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $2.4 to $1.1.

 benchmark-maintains-buy-on-agilon-health-lowers-price-target-to-15

Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $4 to $1.5.

 barclays-maintains-underweight-on-agilon-health-lowers-price-target-to-15

Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $3 to $1.5.

 citigroup-downgrades-agilon-health-to-neutral-lowers-price-target-to-1

Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Buy to Neutral and lowers the price target from...

 agilon-health-q2-eps-025-misses-012-estimate-sales-1395b-miss-1472b-estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION